We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 24.50
Low: 24.50
Prev. Close: 24.50
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thalassa subsidiary initial FinTech acquisition

31 Jul 2019 07:00

RNS Number : 2594H
Thalassa Holdings Limited
31 July 2019
 

Thalassa Holdings Ltd

(Reuters: THAL.L, Bloomberg: THAL:LN)

("Thalassa", "THAL" or the "Company")

Thalassa subsidiary initial FinTech acquisition

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

The board of Thalassa (the "Board") is delighted to announce its maiden FinTech investment in line with its stated investment policy. The Company's wholly owned Swiss subsidiary, Apeiron Holdings A.G. ("Apeiron"), has exchanged a contract, which is expected to complete by the end of September 2019, for the acquisition of id4 A.G. ("id4"), a RegTech[1] company registered in the Swiss Canton of Luzern.

id4 has developed technology, which it is starting to commercialise, to assist financial institutions and other regulated entities to comply, in particular, with Know Your Client, Anti-Money Laundering and client onboarding compliance obligations.

The id4 opportunity was sourced and managed by Apeiron's recently appointed CFO, Rémy Schimmel, following an introduction by Luzern Business (www.luzern-business.ch), the business development office for the Canton of Luzern. Prior to joining Apeiron, Rémy was CFO of Coutts Private Bank, Zürich and most recently CFO of Cembra Money Bank, Zürich. Mr Schimmel joined Apeiron in April 2019.

The acquisition of id4 will be made on a share for share basis, which will result in the shareholders of id4 owning a maximum of 20% of Apeiron at closing. id4 will be valued at up to CHF7 million (c$7.07 million) and Apeiron at up to CHF35 million (c.$35.35 million). The exact valuation attributable to id4 will depend upon the treatment of the acquisition by the Swiss Tax authorities, which, if required, is expected to be known in early September ("Swiss Tax Ruling"). The final valuation will not affect Thalassa's post transaction ownership of 80% of Apeiron.

It is anticipated that the acquisition of id4, which is subject to execution and registration of transaction documents and conclusion of any necessary Swiss Tax Ruling, will complete by the end of September 2019. The Company will make further announcements in due course.

Duncan Soukup, chairman of Thalassa said: "The founders of id4 are seasoned professionals all of whom have worked for many years in the banking and financial services industries and who have an exceptionally strong technical proposition. We are in no doubt that id4 will succeed in delivering technological solutions to an area of the finance industry that is only now, due to stringent regulatory requirements, being forced to increase the use of technology to address the unprecedented increase in the level of compliance whilst at the same time reducing the cost of this exercise. I am very much looking forward to working with the id4 team and building out Apeiron's business, for which the Board has great ambitions."

 

"I believe that the timing of our entry into the FinTech/RegTech market is auspicious as Small and Medium Sized Financial Enterprises are struggling with an unprecedented increase in the level and associated cost of regulatory oversight following the 2008 financial crisis, a problem which can only be addressed through the adoption of new technologies."

 

"Id4 represents Apeiron's first FinTech acquisition in an expected series of further acquisitions in related RegTech disciplines, which will allow the founders of acquired companies to focus on developing their businesses whilst the board of Apeiron focuses on guidance, support and funding of the capital needs of its holdings."

 

 

END

 

 

The ISIN for the Thalassa ordinary shares is VGG878801031.

 

 

Enquiries:

 

Thalassa Holdings Ltd

 

Duncan Soukup (Executive Chairman)

+33 (0)6 78 63 26 89

WH Ireland Limited (Financial Adviser)

+44 (0)207 220 1650

Chris Fielding, Managing Director, Corporate Finance

 

 

www.thalassaholdingsltd.com  

Note to Editors:

Thalassa Holdings Ltd, incorporated and registered in the BVI, is a holding company with various interests across a number of industries.

 

 

[1] RegTech or Regulatory Technology can be defined as the management of regulatory processes within the financial industry through technology. The main functions of RegTech include regulatory monitoring, reporting, and compliance. RegTech is a rapidly growing sub-sector of the FinTech Industry.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFSEDTIIVIA
Date   Source Headline
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited
23rd Dec 20207:00 amRNSAppointment of Director to Tappit Technologies
3rd Dec 20202:49 pmRNSShare Buy-Back

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.